424B8

Filing

Ensysce Biosciences, Inc. Filed 2022-06-01 Acc 0001493152-22-015634

Documents 1

424B8 , form424b8.htm

Around this filing

2022-06-01 424B8 424B8
2022-06-01 424B8 424B8
2022-06-01 424B8 424B8
2022-06-01 424B8 424B8
2022-05-27 4 Chief Executive Officer bought 97,000 shares at an average $0.50 ($48,299)

Link to a passage

External

SEC EDGAR (opens in new tab)